Cleveland Clinic Rheumatology

Cleveland Clinic offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.

Complement in ANCA Vasculitis: Which Pathway Is Pivotal to the Pathogenesis of ANCA Vasculitis? How the Pathway Is Being Targeted as a Potential Treatment for ANCA Vasculitis?

By Cleveland Clinic Rheumatology FEATURING Adam Brown

153 views

July 27, 2021

Complement in ANCA Vasculitis webcast highlights complement pathways for ANCA Vasculitis.

The Basic and Clinical ...
read more ↘

Comments 0

Login

Login

Join VuMedi

Cleveland Clinic Rheumatology

Complement in ANCA Vasculitis: Which Pathway Is Pivotal to the Pathogenesis of ANCA Vasculitis? How the Pathway Is Being Targeted as a Potential Treatment for ANCA Vasculitis?

Complement in ANCA Vasculitis: Which Pathway Is Pivotal to the Patho…

Cleveland Clinic Rheumatic Case Studies: 32 y/o Male w/ Inflammatory…

Managing Dermatologic Conditions in Rheumatology: How to Differentia…

Neurosarcoidosis or CNS Vasculitis – Same or Different?

Managing Diagnosis Complications at Cleveland Clinic: How Should You…

CNS Vasculitis: Diagnostic Update

GPA and MPA: Is There Still a Role for Conventional Therapy?

Giant Cell Arteritis: How do I Take Care of My Patients?

GPA and MPA: Is There Still a Role for Conventional Therapy? - Part 2

EGPA: Look Carefully at the Heart

Could EGPA be Treated with Biologics?

EGPA: Challenges and Prognosis

Immunomodulatory Drugs (IMIDs) Advances in Disease Pathogenesis

Are 14-3-3 Proteins Important Antigens in Large Vessel Vasculitis?